| Product Name | Indacaterol Maleate (Synonyms: QAB149) |
|---|---|
| CAS | 753498-25-8 |
| Formula | C28H32N2O7 |
| MW | 508.56 |
| Appearance | White to off-white powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Indacaterol Maleate (formerly known as QAB149; QAB-149; Onbrez Breezhale; arcapta neohaler; Onbrez), the maleate salt of indacaterol, is an approved anti-COPD (chronic obstructive pulmonary disease) drug acting as an ultra-long-acting β-adrenoceptor agonist developed by Novartis. β-adrenoceptor is activated with a pKi of 7.36 in. The FDA approved indacaterol in 2009 to treat chronic obstructive pulmonary disease (COPD). Using a dry powder inhaler, the aerosol formulation is administered. When Chinese hamster ovary cells are transfected with human β2 adrenoceptors and have a pEC50 of 8.06, indacaterol inhibits the production of cAMP.
Tags: buy Indacaterol maleate | purchase Indacaterol maleate | Indacaterol maleate cost | order Indacaterol maleate | Indacaterol maleate chemical structure | Indacaterol maleate in vivo | Indacaterol maleate in vitro | Indacaterol maleate formula | Indacaterol maleate molecular weight
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft